Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Acq. announced
Asset disposition
Appointed CFO
Quarterly results
Appointed director
CC transcript

CELGENE CORP (CELG) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/13/2020 4 CELGENE CORP /DE/ (10% Owner) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Sold 2,241 shares @ $102.28, valued at $229.2k
Exercised (in-or-at-the-money) 38,979 options to buy @ $5.88, valued at $229.2k
07/06/2020 4 CELGENE CORP /DE/ (10% Owner) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Bought 108,108 shares @ $92.5, valued at $10M
02/10/2020 SC 13G CELGENE CORP reports a 7.5% stake in Sutro Biopharma, Inc.
02/10/2020 SC 13G/A CELGENE CORP reports a 4.2% stake in BeiGene, Ltd.
12/13/2019 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
12/09/2019 S-4 POS Form S-4 POS - Securities issued, formation of bank or savings and loan holding company [General Instruction G], post-effective amendments:
12/09/2019 S-4 POS Form S-4 POS - Securities issued, formation of bank or savings and loan holding company [General Instruction G], post-effective amendments:
12/09/2019 S-4 POS Form S-4 POS - Securities issued, formation of bank or savings and loan holding company [General Instruction G], post-effective amendments:
12/09/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/09/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/09/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/09/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/09/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/09/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/09/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/09/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/09/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/09/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/09/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/09/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/09/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/09/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/09/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/09/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/09/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/09/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/09/2019 S-4 POS Form S-4 POS - Securities issued, formation of bank or savings and loan holding company [General Instruction G], post-effective amendments:
12/02/2019 25 Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities:
11/22/2019 8-K Completion of Acquisition or Disposition of Assets, Material Modifications to Rights of Security Holders, Financial Statement...
11/22/2019 4 VESSEY RUPERT (PRES., RESEARCH AND EARLY DEV.) has filed a Form 4 on CELGENE CORP /DE/
Txns: Granted 8,634 shares @ $0
Granted 13,906 shares @ $0
Granted 24,209 shares @ $0
Disposed/sold 60,927 shares @ $0
Disposed/sold 613 shares @ $0
Disposed/sold 19,142 options to buy @ $118.57, valued at $2.3M
Disposed/sold 3,125 options to buy @ $109.9, valued at $343.4k
Disposed/sold 3,125 options to buy @ $132.56, valued at $414.3k
Disposed/sold 3,125 options to buy @ $114.08, valued at $356.5k
Disposed/sold 2,344 options to buy @ $100.8, valued at $236.3k
Disposed/sold 9,680 options to buy @ $104.97, valued at $1M
11/22/2019 4 AHMED NADIM (PRES., GLOBAL HEM. AND ONC.) has filed a Form 4 on CELGENE CORP /DE/
Txns: Disposed/sold 6,563 options to buy @ $113.18, valued at $742.8k
Disposed/sold 3,125 options to buy @ $124.06, valued at $387.7k
Disposed/sold 3,125 options to buy @ $135.41, valued at $423.2k
Disposed/sold 5,000 options to buy @ $100.97, valued at $504.9k
Disposed/sold 5,000 options to buy @ $103.26, valued at $516.3k
Disposed/sold 10,548 options to buy @ $83.13, valued at $876.9k
Disposed/sold 10,548 options to buy @ $88.91, valued at $937.8k
Disposed/sold 10,549 options to buy @ $71.43, valued at $753.5k
Disposed/sold 1,563 restricted stock units @ $0
Disposed/sold 2,500 restricted stock units @ $0
Disposed/sold 5,357 restricted stock units @ $0
11/22/2019 4 AHMED NADIM (PRES., GLOBAL HEM. AND ONC.) has filed a Form 4 on CELGENE CORP /DE/
Txns: Granted 8,035 shares @ $0
Granted 17,840 shares @ $0
Disposed/sold 40,694 shares @ $0
Disposed/sold 1,966 shares @ $0
Disposed/sold 1,750 options to buy @ $36.36, valued at $63.6k
Disposed/sold 5,624 options to buy @ $36.47, valued at $205.1k
Disposed/sold 5,626 options to buy @ $36.68, valued at $206.4k
Disposed/sold 9,000 options to buy @ $40.22, valued at $362k
Disposed/sold 5,626 options to buy @ $49.48, valued at $278.4k
Disposed/sold 3,750 options to buy @ $59.24, valued at $222.2k
Disposed/sold 3,750 options to buy @ $71.33, valued at $267.5k
11/22/2019 4 Alles Mark J (CEO, CHAIRMAN OF BOARD) has filed a Form 4 on CELGENE CORP /DE/
Txns: Granted 25,696 shares @ $0
Granted 45,119 shares @ $0
Granted 74,414 shares @ $0
Disposed/sold 366,495 shares @ $0
Disposed/sold 6,252 shares @ $0
Disposed/sold 10,994 options to buy @ $36.96, valued at $406.3k
Disposed/sold 8,326 options to buy @ $36.47, valued at $303.6k
Disposed/sold 8,326 options to buy @ $34.7, valued at $288.9k
Disposed/sold 8,326 options to buy @ $36.68, valued at $305.4k
Disposed/sold 17,500 options to buy @ $40.22, valued at $703.9k
Disposed/sold 12,488 options to buy @ $49.48, valued at $617.9k
11/22/2019 4 Alles Mark J (CEO, CHAIRMAN OF BOARD) has filed a Form 4 on CELGENE CORP /DE/
Txns: Disposed/sold 29,669 options to buy @ $102.18, valued at $3M
Disposed/sold 29,669 options to buy @ $113.18, valued at $3.4M
Disposed/sold 33,880 options to buy @ $124.06, valued at $4.2M
Disposed/sold 33,881 options to buy @ $135.41, valued at $4.6M
Disposed/sold 33,881 options to buy @ $100.97, valued at $3.4M
Disposed/sold 33,881 options to buy @ $103.26, valued at $3.5M
Disposed/sold 59,234 options to buy @ $83.13, valued at $4.9M
Disposed/sold 59,234 options to buy @ $88.91, valued at $5.3M
Disposed/sold 59,234 options to buy @ $71.43, valued at $4.2M
Disposed/sold 17,131 restricted stock units @ $0
Disposed/sold 30,079 options to buy @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy